STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe

Autor: Grehn, M., Mandija, S., Miszczyk, M., Krug, D., Tomasik, B., Stickney, K.E., Alcantara, P., Alongi, F., Anselmino, M., Aranda, R.S., Balgobind, B.V., Boda-Heggemann, J., Boldt, L.H., Bottoni, N., Cvek, J., Elicin, O., De Ferrari, G.M., Hassink, R.J., Hazelaar, C., Hindricks, G., Hurkmans, C., Iotti, C., Jadczyk, T., Jiravsky, O., Jumeau, R., Kristiansen, S.B., Levis, M., López, M.A., Martí-Almor, J., Mehrhof, F., Møller, D.S., Molon, G., Ouss, A., Peichl, P., Plasek, J., Postema, P.G., Quesada, A., Reichlin, T., Rordorf, R., Rudic, B., Saguner, A.M., Ter Bekke, RMA, Torrecilla, J.L., Troost, EGC, Vitolo, V., Andratschke, N., Zeppenfeld, K., Blamek, S., Fast, M., de Panfilis, L., Blanck, O., Pruvot, E., Verhoeff, JJC

Publikováno v: Europace, vol. 25, no. 4, pp. 1284-1295

The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary (STOPSTORM) consortium has been established as a large research network for investigating STere

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::90763df0c7ecf6c19ae077e282230561
https://serval.unil.ch/notice/serval:BIB_32E60A3C4B28

Variable-RBE-induced NTCP predictions for various side-effects following proton therapy for brain tumors - Identification of high-risk patients and risk mitigation.

Autor: Palkowitsch M; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany. Electronic address: martina.palkowitsch@oncoray.de., Kaufmann LM; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany., Hennings F; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany., Menkel S; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany., Hahn C; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; TU Dortmund University, Department of Physics, Dortmund, Germany., Bensberg J; TU Dortmund University, Department of Physics, Dortmund, Germany., Lühr A; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; TU Dortmund University, Department of Physics, Dortmund, Germany., Seidlitz A; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; National Center for Tumor Diseases Dresden (NCT/UCC), Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany., Troost EGC; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; National Center for Tumor Diseases Dresden (NCT/UCC), Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany., Krause M; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; National Center for Tumor Diseases Dresden (NCT/UCC), Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany., Löck S; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Oct 18; Vol. 202, pp. 110590. Date of Electronic Publication: 2024 Oct 18.

The emerging role of Artificial Intelligence in proton therapy: A review.

Autor: Isaksson LJ; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy., Mastroleo F; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy., Vincini MG; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy. Electronic address: mariagiulia.vincini@ieo.it., Marvaso G; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy. Electronic address: Giulia.marvaso@ieo.it., Zaffaroni M; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy., Gola M; Department of Human Histology and Embryology, Collegium Medicum, School of Medicine, University of Warmia and Mazury, Olsztyn 10-082, Poland., Mazzola GC; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy., Bergamaschi L; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy., Gaito S; Proton Clinical Outcomes Unit, The Christie NHS Proton Beam Therapy Centre, Manchester M20 4BX, UK; Division of Clinical Cancer Science, School of Medical Sciences, The University of Manchester Manchester M13 9PL, UK., Alongi F; Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria, 37024 Negrar-Verona, Italy & DSMC, University of Brescia, Brescia, Italy., Doyen J; Centre Antoine-Lacassagne, University of Côte d'Azur, Nice 06189, France; University Côte d'Azur, CNRS UMR 7284, INSERM U1081, Centre Antoine Lacassagne, Institute for Research on Cancer and Aging of Nice (IRCAN), 06189 Nice, France, Centre Antoine Lacassagne, Nice 06189, France., Fossati P; EBG MedAustron GmbH, Marie-Curie-Str. 5, Wiener Neustadt 2700, Austria; Department of General and Translational Oncology and Hematology, Karl Landsteiner University of Health Sciences, Krems an der Donau, 3500, Austria., Haustermans K; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Høyer M; Aarhus University (AU), Nordre Ringgade 1, Aarhus C 8000, Denmark., Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Matute R; Centro de Protonterapia Quironsalud, Pozuelo de Alarcón, Madrid 28223, Spain., Orlandi E; Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy., Schwarz M; Radiation Oncology Department, University of Washington, Seattle, WA 98109, USA., Troost EGC; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden 01309, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden 01307, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden 01309, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-OncoRay, Dresden 01328, Germany., Vondracek V; Proton Therapy Centre Czech, Prague, Czech Republic and Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czech Republic., La Torre D; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy; SKEMA Business School, Université Côte d'Azur, Sophia Antipolis, France., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan 20141, Italy., Petralia G; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy; Division of Radiology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy., Orecchia R; Scientific Directorate, IEO European Institute of Oncology IRCCS, Milan 20141, Italy., Alterio D; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy., Jereczek-Fossa BA; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy.

Publikováno v: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Sep 02; Vol. 204, pp. 104485. Date of Electronic Publication: 2024 Sep 02.

Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients.

Autor: Igbo BT; Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany., Jentsch C; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany., Linge A; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany, German Cancer Research Center (DKFZ), Heidelberg; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Plesca I; Institute of immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kuzay Y; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany, German Cancer Research Center (DKFZ), Heidelberg; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Löck S; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany, German Cancer Research Center (DKFZ), Heidelberg; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Kumaravadivel MS; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany., Doms S; Institute of immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Stolz-Kieslich L; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany., Pollack D; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany., Brückmann S; Institute for Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Tittlbach H; Institute for Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Weitz J; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany, German Cancer Research Center (DKFZ), Heidelberg; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Department of Visceral, Thoracic and Vascular Surgery (VTG), Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, Dresden, Germany., Aust D; Institute of immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute for Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Apolle R; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany, German Cancer Research Center (DKFZ), Heidelberg; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Schmitz M; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany, German Cancer Research Center (DKFZ), Heidelberg; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Institute of immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Troost EGC; Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany. Esther.Troost@uniklinikum-dresden.de.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany. Esther.Troost@uniklinikum-dresden.de.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany. Esther.Troost@uniklinikum-dresden.de.; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany. Esther.Troost@uniklinikum-dresden.de.; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany, German Cancer Research Center (DKFZ), Heidelberg; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. Esther.Troost@uniklinikum-dresden.de.; Institute for Pathology and Tumor and Normal Tissue Bank of the University Cancer Center (UCC), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Esther.Troost@uniklinikum-dresden.de.

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Jul; Vol. 200 (7), pp. 595-604. Date of Electronic Publication: 2024 May 10.

A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.

Autor: Samuels M; 'Banner MD Anderson Cancer Center, Phoenix, Arizona, USA., Falkenius J; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., Bar-Ad V; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania., Dunst J; Department of Radiotherapy, University Hospital Schleswig-Holstein, Lübeck, Germany., van Triest B; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Yachnin J; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., Rodriguez-Gutierrez A; Merck S.L.U., Madrid, Spain, an affiliate of Merck KGaA, Darmstadt, Germany., Kuipers M; The health care business of Merck KGaA, Darmstadt, Germany., You X; EMD Serono, Billerica, MA, USA., Sarholz B; The health care business of Merck KGaA, Darmstadt, Germany., Locatelli G; The health care business of Merck KGaA, Darmstadt, Germany., Becker A; The health care business of Merck KGaA, Darmstadt, Germany., Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; National Center for Tumor Diseases, Partner Site Dresden, Germany; German Cancer Research Center, Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany. Electronic address: Esther.Troost@uniklinikum-dresden.de.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Mar 01; Vol. 118 (3), pp. 743-756. Date of Electronic Publication: 2023 Sep 24.